Veracyte, Inc.
VCYT
$46.41
$0.140.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.28% | 16.91% | 16.01% | 16.41% | 19.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.28% | 16.91% | 16.01% | 16.41% | 19.91% |
| Cost of Revenue | 4.81% | 6.82% | 5.50% | 22.07% | 20.98% |
| Gross Profit | 22.62% | 21.28% | 20.78% | 14.15% | 19.45% |
| SG&A Expenses | -0.31% | 1.92% | 9.82% | 2.94% | 7.12% |
| Depreciation & Amortization | -5.72% | -8.13% | -11.42% | -15.00% | -19.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.35% | 4.96% | 6.41% | 7.51% | 10.55% |
| Operating Income | 141.99% | 197.23% | 203.87% | 368.98% | 3,570.41% |
| Income Before Tax | 300.50% | 158.69% | 164.92% | 479.51% | 152.87% |
| Income Tax Expenses | -41.65% | 34.61% | 15.07% | -36.83% | 451.20% |
| Earnings from Continuing Operations | 334.72% | 166.31% | 174.89% | 427.11% | 148.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 334.72% | 166.31% | 174.89% | 427.11% | 148.73% |
| EBIT | 141.99% | 197.23% | 203.87% | 368.98% | 3,570.41% |
| EBITDA | 85.49% | 105.81% | 93.38% | 110.15% | 136.42% |
| EPS Basic | 323.61% | 159.69% | 168.82% | 375.89% | 145.78% |
| Normalized Basic EPS | 101.27% | 156.62% | 159.88% | 135.06% | 281.27% |
| EPS Diluted | 325.03% | 161.37% | 174.97% | 349.37% | 143.73% |
| Normalized Diluted EPS | 99.60% | 157.46% | 160.92% | 135.87% | 277.82% |
| Average Basic Shares Outstanding | 2.05% | 2.15% | 2.75% | 3.76% | 4.65% |
| Average Diluted Shares Outstanding | 2.41% | 1.65% | 2.98% | 4.79% | 6.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |